Principal Financial Group Inc. Has $16.87 Million Stock Holdings in LifeStance Health Group, Inc. $LFST

Principal Financial Group Inc. trimmed its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 10.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,066,371 shares of the company’s stock after selling 349,653 shares during the quarter. Principal Financial Group Inc. owned approximately 0.79% of LifeStance Health Group worth $16,865,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AustralianSuper Pty Ltd acquired a new stake in shares of LifeStance Health Group during the 3rd quarter worth approximately $17,056,000. Vanguard Personalized Indexing Management LLC bought a new position in LifeStance Health Group in the third quarter valued at approximately $72,000. Covestor Ltd grew its holdings in LifeStance Health Group by 131.4% during the 3rd quarter. Covestor Ltd now owns 24,650 shares of the company’s stock worth $136,000 after acquiring an additional 13,997 shares during the period. Wealth Enhancement Advisory Services LLC bought a new stake in shares of LifeStance Health Group during the 3rd quarter valued at $147,000. Finally, State of Alaska Department of Revenue acquired a new position in shares of LifeStance Health Group in the 3rd quarter valued at $124,000. 85.50% of the stock is owned by institutional investors.

Insider Transactions at LifeStance Health Group

In other news, insider Ann Varanakis sold 50,000 shares of the company’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $6.90, for a total value of $345,000.00. Following the sale, the insider directly owned 315,610 shares of the company’s stock, valued at approximately $2,177,709. This represents a 13.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert Bessler sold 119,942 shares of LifeStance Health Group stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $7.04, for a total value of $844,391.68. Following the transaction, the director owned 1,318,983 shares of the company’s stock, valued at $9,285,640.32. The trade was a 8.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 327,326 shares of company stock worth $2,259,317 in the last ninety days. Insiders own 6.60% of the company’s stock.

Analyst Ratings Changes

LFST has been the subject of a number of recent analyst reports. Barclays initiated coverage on LifeStance Health Group in a report on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price objective for the company. UBS Group upped their price target on LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Friday, November 7th. BTIG Research lifted their price objective on shares of LifeStance Health Group from $10.00 to $11.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. BMO Capital Markets began coverage on shares of LifeStance Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $8.00 price objective for the company. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “hold” rating to a “buy” rating in a report on Sunday. Two investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, LifeStance Health Group has an average rating of “Moderate Buy” and an average price target of $9.00.

LifeStance Health Group Stock Down 0.3%

NASDAQ:LFST opened at $6.81 on Tuesday. LifeStance Health Group, Inc. has a twelve month low of $3.74 and a twelve month high of $8.30. The firm has a market capitalization of $2.65 billion, a price-to-earnings ratio of -227.00 and a beta of 1.12. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.18. The stock’s 50 day moving average price is $7.02 and its two-hundred day moving average price is $5.93.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.